New Delhi: ENTOD Pharmaceuticals, in collaboration with the Matanand Welfare Foundation, successfully concluded the National Hearing Week 2025, under the theme “Hear Their World: Early Detection, Early Action.” The week-long initiative focused on children, with the aim to raise awareness about congenital hearing loss and highlight the need for early detection and preventive care. By reaching three crore people across India, the campaign helped improve awareness and access to paediatric hearing healthcare.
The initiative gained strong momentum both online and offline, engaging thousands across the country and bringing together healthcare professionals, influencers, and volunteers. More than 1200 free hearing screening camps were conducted in clinics, hospitals, and community centres, ensuring early diagnosis opportunities for children. The campaign’s social media efforts also had a significant impact, with #HarBacchaSunega trending at number two on X (formerly Twitter) and reaching millions nationwide. On the other hand, the social media campaign reached 25 million people.
To amplify the message further, a national radio awareness campaign aired on 92.7 BIG FM in Mumbai, Ahmedabad, Kolkata, Lucknow, and Bangalore. Over 1200 physical camps and 20+ walkathons and rallies, along with ENT specialists at clinics, hospitals, five street skits and community centres were organised across INDIA. Over 100 awareness videos featuring top ENT specialists were shared on social media, while more than 20 school awareness camps educated parents and children about hearing health. Additionally, five major walkathons and rallies brought communities together in support of the cause.
Additionally, funds raised through Matanand.org and ENTOD’s CSR initiatives will support cochlear implant surgeries for children from underprivileged backgrounds, ensuring they have access to critical treatment and a better quality of life.
The campaign’s impact was strengthened by the participation of over 105 ENT specialists and 100 social media influencers, who helped emphasise the importance of early intervention for congenital hearing loss. Awareness camps were also conducted for 
healthcare workers, ASHA, and Anganwadi members to help them identify hearing disabilities in children at the community level.
Nikkhil K Masurkar, CEO of ENTOD Pharmaceuticals, shared the vision behind the initiative, saying, “National Hearing Week 2025 has been a significant milestone in raising awareness about congenital hearing loss. Through 1200+ free hearing camps, a nationwide radio campaign, and a dynamic social media movement, we have reached millions across India, but this is just the beginning. Our mission is to ensure that every child, regardless of background, has the opportunity to hear, speak, and thrive. The funds raised will support cochlear implants for underprivileged children, strengthening our commitment to making hearing care accessible to all.”
Dr. Sanjeev Pethe, M.S. ENT, stressed the importance of early diagnosis, saying, “Congenital hearing loss is more common than people think, yet many cases go unnoticed until it’s too late. Without early intervention, children struggle with speech, education, and social interactions. National Hearing Week 2025 is a crucial step in spreading awareness and inspiring action. This initiative is a reminder for parents, teachers, and healthcare professionals to make hearing screenings a priority so that no child is denied the ability to hear and communicate.”
Although National Hearing Week 2025 has concluded, ENTOD Pharmaceuticals remains committed to making hearing healthcare accessible for all children. The success of this campaign marks the beginning of sustained efforts to educate communities, provide screenings, and support children with hearing disabilities across India.